Uncontrolled mitotic kinesin activity leads to tumorigenesis and drug resistance, which these fused heterocyclic scaffolds mitigate through targeted HSET protein inhibition. Precise chemical substitution on bicyclic and tricyclic cores enables selective binding to prevent aberrant spindle assembly.